Blood Cancer Journal (Sep 2024)
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
- Bon-Kwan Koo,
- Eun-Ji Choi,
- Ju Hyun Moon,
- Ji Yun Kim,
- Hyunkyung Park,
- Han-Seung Park,
- Yunsuk Choi,
- Jung-Hee Lee,
- Kyoo-Hyung Lee,
- Eun Kyung Choi,
- Eunji Kim,
- Je-Hwan Lee,
- Eun-Hye Hur
Affiliations
- Bon-Kwan Koo
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Eun-Ji Choi
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Ju Hyun Moon
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Ji Yun Kim
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Hyunkyung Park
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Han-Seung Park
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Yunsuk Choi
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Jung-Hee Lee
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Kyoo-Hyung Lee
- Department of Hematology-Oncology, Ewha Woman’s University Medical Center, Mokdong Hospital
- Eun Kyung Choi
- Asan Preclinical Evaluation Center for Cancer Therapeutics, Asan Medical Center
- Eunji Kim
- R&D Institute, Yungjin Pharmaceutical Co., Ltd
- Je-Hwan Lee
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- Eun-Hye Hur
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine
- DOI
- https://doi.org/10.1038/s41408-024-01141-4
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 5
Abstract
No abstracts available.
